MedPath

Moxidectin

MOXIDECTIN tablets, for oral use These highlights do not include all the information needed to use MOXIDECTIN safely and effectively. See full prescribing information for MOXIDECTIN . Initial U.S. Approval: 2018

Approved
Approval ID

6eb02ae9-9065-176f-e053-2991aa0ac891

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2023

Manufacturers
FDA

Medicines Development for Global Health

DUNS: 754191398

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Moxidectin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71705-050
Application NumberNDA210867
Product Classification
M
Marketing Category
C73594
G
Generic Name
Moxidectin
Product Specifications
Route of AdministrationORAL
Effective DateNovember 30, 2023
FDA Product Classification

INGREDIENTS (1)

MOXIDECTINActive
Quantity: 2 mg in 1 1
Code: NGU5H31YO9
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.